Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Clinical trial NCT05489783 · RECRUITING
Trial details
- NCT number
- NCT05489783
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-29
- Primary completion
- 2026-07-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.